[
  {
    "ts": "2025-12-04T21:20:00+00:00",
    "headline": "CooperCompanies Announces New Chair of the Board and Strategic Review",
    "summary": "SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking his final term. The Company also announced a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value. “Bob’s visi",
    "url": "https://finance.yahoo.com/news/coopercompanies-announces-chair-board-strategic-212000048.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "29f535e2-06c8-375d-94d6-e6f0367b8edb",
      "content": {
        "id": "29f535e2-06c8-375d-94d6-e6f0367b8edb",
        "contentType": "STORY",
        "title": "CooperCompanies Announces New Chair of the Board and Strategic Review",
        "description": "",
        "summary": "SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking his final term. The Company also announced a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value. “Bob’s visi",
        "pubDate": "2025-12-04T21:20:00Z",
        "displayTime": "2025-12-04T21:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336",
          "originalWidth": 1999,
          "originalHeight": 398,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/APivsR0wIx9EpJnj2qiPaQ--~B/aD0zOTg7dz0xOTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336.cf.webp",
              "width": 1999,
              "height": 398,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F961D8k.2wRkP2HE_Ygb6g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-announces-chair-board-strategic-212000048.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-announces-chair-board-strategic-212000048.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T21:15:00+00:00",
    "headline": "CooperCompanies Announces Fourth Quarter and Full Year 2025 Results",
    "summary": "SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025. Fourth quarter 2025 revenue of $1,065.2 million, up 5%, or up 3% organically. Fiscal year 2025 revenue of $4.1 billion, up 5%, or up 4% organically.Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.43, down 27%. Fiscal 2025 GAAP diluted EPS of $1.87, down 4%.",
    "url": "https://finance.yahoo.com/news/coopercompanies-announces-fourth-quarter-full-211500545.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "76669339-5e0e-337d-a436-54ea42201f8e",
      "content": {
        "id": "76669339-5e0e-337d-a436-54ea42201f8e",
        "contentType": "STORY",
        "title": "CooperCompanies Announces Fourth Quarter and Full Year 2025 Results",
        "description": "",
        "summary": "SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full year ended October 31, 2025. Fourth quarter 2025 revenue of $1,065.2 million, up 5%, or up 3% organically. Fiscal year 2025 revenue of $4.1 billion, up 5%, or up 4% organically.Fourth quarter 2025 GAAP diluted earnings per share (EPS) of $0.43, down 27%. Fiscal 2025 GAAP diluted EPS of $1.87, down 4%.",
        "pubDate": "2025-12-04T21:15:00Z",
        "displayTime": "2025-12-04T21:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336",
          "originalWidth": 1999,
          "originalHeight": 398,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/APivsR0wIx9EpJnj2qiPaQ--~B/aD0zOTg7dz0xOTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336.cf.webp",
              "width": 1999,
              "height": 398,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F961D8k.2wRkP2HE_Ygb6g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e2d8ce2a729db90c9d1df5203e1f1336.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-announces-fourth-quarter-full-211500545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-announces-fourth-quarter-full-211500545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T21:45:06+00:00",
    "headline": "CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars",
    "summary": "Medical device company CooperCompanies (NASDAQ:COO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.6% year on year to $1.07 billion. The company expects next quarter’s revenue to be around $1.02 billion, coming in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.15 per share was 3.2% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/coopercompanies-nasdaq-coo-reports-q3-214506679.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "6c4b9196-da20-3ac4-90e1-4284c5ad700e",
      "content": {
        "id": "6c4b9196-da20-3ac4-90e1-4284c5ad700e",
        "contentType": "STORY",
        "title": "CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars",
        "description": "",
        "summary": "Medical device company CooperCompanies (NASDAQ:COO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.6% year on year to $1.07 billion. The company expects next quarter’s revenue to be around $1.02 billion, coming in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.15 per share was 3.2% above analysts’ consensus estimates.",
        "pubDate": "2025-12-04T21:45:06Z",
        "displayTime": "2025-12-04T21:45:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/5b270a11544b3de2ee696c976becc425",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "COO Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6ACi05CcwQdIpmLIQ.3vVg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/5b270a11544b3de2ee696c976becc425.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.fhlzT92lTrG6eB7aSAjTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/5b270a11544b3de2ee696c976becc425.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-nasdaq-coo-reports-q3-214506679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/coopercompanies-nasdaq-coo-reports-q3-214506679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]